title: The use of chitosan-6-mercaptonicotinic acid nanoparticles for oral peptide drug delivery.
authors.affiliation: University of Innsbruck, Pharmaceutical Technology, Innrain 52c, Innsbruck, 6020 Austria.
authors.forename: Gioconda
authors.initials: G
authors.lastname: Millotti
authors.forename: Glen
authors.initials: G
authors.lastname: Perera
authors.forename: Claudia
authors.initials: C
authors.lastname: Vigl
authors.forename: Karin
authors.initials: K
authors.lastname: Pickl
authors.forename: Frank Michael
authors.initials: FM
authors.lastname: Sinner
authors.forename: Andreas
authors.initials: A
authors.lastname: Bernkop-Schnürch
mesh_terms: D000268:Adhesiveness; D000284:Administration, Oral; D000818:Animals; D019540:Area Under Curve; D018938:Caco-2 Cells; D048271:Chitosan / Q000031:analogs & derivatives* / Q000737:chemistry* / Q000633:toxicity; D004337:Drug Carriers / Q000737:chemistry / Q000633:toxicity; D016503:Drug Delivery Systems; D004355:Drug Stability; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D007328:Insulin / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000633:toxicity; D008297:Male; D053758:Nanoparticles; D010316:Particle Size; D051381:Rats; D017207:Rats, Sprague-Dawley; D013438:Sulfhydryl Compounds / Q000737:chemistry* / Q000633:toxicity
chemical_list: D004337:Drug Carriers; D007328:Insulin; D013438:Sulfhydryl Compounds; C559281:chitosan-6-mercaptonicotinic acid; D048271:Chitosan